Related Experiment Videos
Noradrenaline: friend or foe?
1Department of Intensive Care and Medicine, Austin & Repatriation Medical Centre, Melbourne, Australia. rb@austin.unimelb.edu.au
Heart, Lung & Circulation
|December 15, 2005
Summary
Norepinephrine (NE) is a vasopressor that may improve organ blood flow in vasodilated states, contrary to common fears. When used appropriately, NE can be beneficial for kidney and visceral perfusion, enhancing patient outcomes.
Area of Science:
- Critical care medicine
- Cardiovascular physiology
- Pharmacology
Background:
- Systemic hypotension is common in septic shock, systemic inflammation, and vasodilated states, often persisting despite fluid resuscitation.
- Norepinephrine (NE) is a vasopressor used to increase arterial pressure, but concerns exist about its potential to impair renal and visceral blood flow.
- Vasodilated states may involve impaired peripheral vascular responsiveness, suggesting NE might have different effects than in normal circulatory conditions.
Purpose of the Study:
- To evaluate the effects of norepinephrine (NE) on organ perfusion, particularly renal and visceral blood flow, in patients with vasodilated states.
- To address the clinical fear that NE administration negatively impacts visceral organ function.
- To determine if NE can improve organ perfusion pressure and subsequent organ function in conditions like septic shock.
Main Methods:
- Review of animal studies demonstrating NE's positive effects on GFR and renal blood flow.
- Analysis of physiological data showing NE increases renal blood flow independent of pressure effects in endotoxin models.
- Examination of patient series and clinical experience in septic and cardiac patients receiving NE for vasodilatation.
Main Results:
- Animal data suggest NE improves GFR and renal blood flow by increasing perfusion pressure.
- Physiological analysis indicates NE can increase renal blood flow even after controlling for pressure effects.
- Clinical observations and patient series report positive effects of NE on GFR and urine output.
- Clinical experience shows NE positively impacts coronary blood flow in vasodilated patients.
Conclusions:
- Norepinephrine (NE) may improve visceral organ blood flow in vasodilated states by selectively increasing organ perfusion pressure.
- Concerns about NE impairing renal and visceral blood flow appear unfounded in vasodilated conditions.
- When used appropriately after adequate fluid resuscitation and with normal/increased cardiac output, NE is likely beneficial for organ perfusion.